71 related articles for article (PubMed ID: 12085221)
41. [Recent improvements in antiemetic therapy].
Roila F; Palladino MA; Ciccarese G; Basurto C
Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
[TBL] [Abstract][Full Text] [Related]
42. A risk-benefit assessment of serotonin 5-HT3 receptor antagonists in antineoplastic therapy-induced emesis.
Perez EA
Drug Saf; 1998 Jan; 18(1):43-56. PubMed ID: 9466087
[TBL] [Abstract][Full Text] [Related]
43. [Anti-5-HT-3: a new group of antiemetics].
Galindo JR
Rev Clin Esp; 1996 Feb; 196(2):119-24. PubMed ID: 8685484
[No Abstract] [Full Text] [Related]
44. [From cocaine to innovative antiemetics. The medicinal chemistry of 5-ht3 receptor antagonists].
Zettl H; Schubert-Zsilavecz M; Siebert CD
Pharm Unserer Zeit; 2007; 36(5):354-61. PubMed ID: 17722162
[No Abstract] [Full Text] [Related]
45. Advances in use of the 5-HT3 receptor antagonists.
Walton SM
Expert Opin Pharmacother; 2000 Jan; 1(2):207-23. PubMed ID: 11249543
[TBL] [Abstract][Full Text] [Related]
46. 5-HT3-receptor antagonists in the control of delayed-onset emesis.
Gridelli C
Anticancer Res; 2003; 23(3C):2773-82. PubMed ID: 12926112
[TBL] [Abstract][Full Text] [Related]
47. Are granisetron and ondansetron equivalent in the clinic?
Dilly S
Eur J Cancer; 1992; 28A Suppl 1():S32-5. PubMed ID: 1320918
[TBL] [Abstract][Full Text] [Related]
48. Granisetron in the control of radiotherapy-induced nausea and vomiting: a comparison with other antiemetic therapies.
Feyer P; Seegenschmiedt MH; Steingraeber M
Support Care Cancer; 2005 Sep; 13(9):671-8. PubMed ID: 16044252
[TBL] [Abstract][Full Text] [Related]
49. Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?
Gan TJ
CNS Drugs; 2005; 19(3):225-38. PubMed ID: 15740177
[TBL] [Abstract][Full Text] [Related]
50. Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting.
Plosker GL; Benfield P
Pharmacoeconomics; 1996 Apr; 9(4):357-74. PubMed ID: 10160110
[TBL] [Abstract][Full Text] [Related]
51. [Chemotherapy-induced emesis and serotonin antagonists].
Jantunen I; Johansson R
Duodecim; 1991; 107(14):1112-5. PubMed ID: 1670506
[No Abstract] [Full Text] [Related]
52. Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics.
Morrow GR; Roscoe JA; Kirshner JJ; Hynes HE; Rosenbluth RJ
Support Care Cancer; 1998 May; 6(3):244-7. PubMed ID: 9629877
[TBL] [Abstract][Full Text] [Related]
53. Stratified administration of serotonin 5-HT3 receptor antagonists (setrons) for chemotherapy-induced emesis. Economic implications.
Sanchez LA; Holdsworth M; Bartel SB
Pharmacoeconomics; 2000 Dec; 18(6):533-56. PubMed ID: 11227393
[TBL] [Abstract][Full Text] [Related]
54. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
Morrow GR; Hickok JT; Rosenthal SN
Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
[TBL] [Abstract][Full Text] [Related]
55. [Prophylaxis of chemotherapy-induced vomiting and nausea].
Tóth J; Szántó J
Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
[TBL] [Abstract][Full Text] [Related]
56. The vomiting reflex and the role of 5-HT3 receptors.
Freeman AJ; Bountra C; Dale TJ; Gardner CJ; Twissell DJ
Anticancer Drugs; 1993 Dec; 4 Suppl 2():9-15. PubMed ID: 7511008
[No Abstract] [Full Text] [Related]
57. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.
Kris MG; Tyson LB; Clark RA; Gralla RJ
Cancer; 1992 Aug; 70(4 Suppl):1012-6. PubMed ID: 1386282
[TBL] [Abstract][Full Text] [Related]
58. Prophylaxis with oral granisetron for acute emesis induced by moderately emetogenic chemotherapy.
Hesketh P
Semin Oncol; 1995 Aug; 22(4 Suppl 10):19-23. PubMed ID: 7570050
[No Abstract] [Full Text] [Related]
59. Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.
Kidgell AE; Butcher ME; Brown GW
Cancer Treat Rev; 1990 Sep; 17(2-3):311-7. PubMed ID: 2176933
[No Abstract] [Full Text] [Related]
60. The efficacy of 5-HT3 receptor antagonists for the prevention of postoperative nausea and vomiting after craniotomy: a meta-analysis.
Neufeld SM; Newburn-Cook CV
J Neurosurg Anesthesiol; 2007 Jan; 19(1):10-7. PubMed ID: 17198095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
